Anti-Covid Drug Trial Shows "Robust Efficacy": AstraZeneca

Pharmaceutical giant AstraZeneca on Thursday announced that clinical trials of an antibody-based COVID-19 drug had shown robust efficacy and long-term prevention.

from NDTV News - World-news